Total Payments
$8,957
2024 Payments
$2,652
Companies
39
Transactions
635
Medicare Patients
3,805
Medicare Billing
$210,774
Payment Breakdown by Category
Food & Beverage$8,944 (99.8%)
Education$13.89 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,944 | 634 | 99.8% |
| Education | $13.89 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,414 | 113 | $0 (2024) |
| ABBVIE INC. | $1,175 | 102 | $0 (2024) |
| GlaxoSmithKline, LLC. | $905.54 | 70 | $0 (2024) |
| Lilly USA, LLC | $787.09 | 55 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $647.59 | 50 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $576.89 | 35 | $0 (2024) |
| Merck Sharp & Dohme LLC | $473.84 | 26 | $0 (2024) |
| Amgen Inc. | $356.64 | 22 | $0 (2024) |
| PFIZER INC. | $348.73 | 24 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $263.11 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,652 | 155 | Novo Nordisk Inc ($482.91) |
| 2023 | $2,342 | 165 | ABBVIE INC. ($378.53) |
| 2022 | $2,222 | 172 | ABBVIE INC. ($308.43) |
| 2021 | $1,742 | 143 | AbbVie Inc. ($334.76) |
All Payment Transactions
635 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: Diabetes | ||||||
| 12/19/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: Oncology | ||||||
| 12/16/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: PSYCHIATRY | ||||||
| 12/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: RESPIRATORY | ||||||
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: Respiratory | ||||||
| 12/09/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: Bone Health | ||||||
| 12/06/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Obesity | ||||||
| 12/05/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: VACCINES | ||||||
| 12/03/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Insomnia | ||||||
| 12/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $8.40 | General |
| Category: Diabetes | ||||||
| 12/02/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: Diabetes | ||||||
| 11/25/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: Oncology | ||||||
| 11/15/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: RESPIRATORY | ||||||
| 11/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: DIABETES | ||||||
| 11/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: Obesity | ||||||
| 11/11/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $12.42 | General |
| Category: VACCINES | ||||||
| 11/11/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $1.02 | General |
| Category: VACCINES | ||||||
| 11/08/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Respiratory | ||||||
| 11/05/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, CAPVAXIVE | Food and Beverage | In-kind items and services | $24.48 | General |
| Category: VACCINE | ||||||
| 11/04/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.32 | General |
| Category: NEUROSCIENCE | ||||||
| 10/28/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Diabetes | ||||||
| 10/25/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $25.34 | General |
| Category: Cardiovascular | ||||||
| 10/25/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: Endocrinology | ||||||
| 10/22/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,363 | 1,925 | $181,029 | $85,315 |
| 2022 | 15 | 1,383 | 1,970 | $160,809 | $77,255 |
| 2021 | 11 | 839 | 1,180 | $86,080 | $39,563 |
| 2020 | 10 | 220 | 246 | $15,020 | $8,640 |
Total Patients
3,805
Total Services
5,321
Medicare Billing
$210,774
Procedure Codes
54
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 182 | 402 | $69,144 | $26,870 | 38.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 154 | 154 | $33,726 | $16,199 | 48.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 184 | 333 | $36,630 | $15,939 | 43.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 57 | 57 | $5,187 | $4,028 | 77.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 14 | 14 | $5,040 | $3,941 | 78.2% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 30 | 30 | $5,100 | $3,726 | 73.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 176 | 305 | $3,660 | $2,548 | 69.6% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 153 | 153 | $3,825 | $2,292 | 59.9% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 13 | 15 | $3,600 | $1,878 | 52.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 59 | 59 | $2,419 | $1,738 | 71.8% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 28 | 31 | $1,674 | $1,257 | 75.1% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 30 | 30 | $1,560 | $1,139 | 73.0% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 62 | 62 | $1,611 | $934.96 | 58.0% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 16 | 17 | $1,564 | $932.44 | 59.6% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 25 | 30 | $3,528 | $685.24 | 19.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 154 | 195 | $1,755 | $421.08 | 24.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 14 | 14 | $406.00 | $397.88 | 98.0% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 12 | 24 | $600.00 | $389.28 | 64.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 234 | 585 | $64,350 | $28,885 | 44.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 151 | 151 | $30,919 | $16,147 | 52.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 121 | 162 | $27,864 | $12,280 | 44.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 54 | 54 | $4,914 | $3,701 | 75.3% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 166 | 166 | $4,316 | $2,539 | 58.8% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2022 | 52 | 56 | $3,024 | $2,288 | 75.7% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 151 | 151 | $3,775 | $2,269 | 60.1% |
About Shelby Bare, CRNP
Shelby Bare, CRNP is a Family healthcare provider based in Hanover, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/21/2020. The National Provider Identifier (NPI) number assigned to this provider is 1558979062.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Shelby Bare, CRNP has received a total of $8,957 in payments from pharmaceutical and medical device companies, with $2,652 received in 2024. These payments were reported across 635 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($8,944).
As a Medicare-enrolled provider, Bare has provided services to 3,805 Medicare beneficiaries, totaling 5,321 services with total Medicare billing of $210,774. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Hanover, PA
- Active Since 07/21/2020
- Last Updated 07/21/2020
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1558979062
Products in Payments
- TRELEGY ELLIPTA (Drug) $605.78
- VRAYLAR (Drug) $578.36
- Ozempic (Drug) $520.38
- Rybelsus (Drug) $382.29
- JARDIANCE (Drug) $378.21
- ELIQUIS (Drug) $374.93
- MOUNJARO (Drug) $345.35
- Wegovy (Drug) $300.09
- STIOLTO RESPIMAT (Drug) $280.83
- XARELTO (Drug) $263.11
- QULIPTA (Drug) $256.05
- XIFAXAN (Drug) $243.31
- BREZTRI (Drug) $212.19
- FARXIGA (Drug) $202.50
- EMGALITY (Drug) $192.56
- NURTEC ODT (Drug) $173.33
- Kerendia (Drug) $164.32
- AIRSUPRA (Drug) $148.63
- EVENITY (Biological) $140.63
- LINZESS (Drug) $127.90
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Hanover
Irina Dauphinee, Pmhnp, Fnp, PMHNP, FNP
Family — Payments: $13,016
Family $13,016
Denise Miller, Crnp, CRNP
Family — Payments: $7,186
Family $7,186
Nicole Roberts, Crnp, CRNP
Family — Payments: $6,819
Family $6,819
Dana Yealy, Crnp, CRNP
Family — Payments: $3,617
Family $3,617
Tamara Royalty, Fnp-C, FNP-C
Family — Payments: $3,083
Family $3,083
Beth Covington, Np-C, NP-C
Family — Payments: $1,244
Family $1,244